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NTERA2/D1 human teratocarcinoma progenitors induced to dif-
ferentiate into postmitotic neurons by either long-term treatment
with retinoic acid or short-term treatment with the nucleoside
analog cytosine β-D-arabinofuranoside were subjected to mor-
phometric analysis and compared. Our data provide a methodo-
logical and conceptual framework for future investigations aiming
at distinguishing neuronal phenotypes on the basis of morpho-
metric analysis. Data presented here are related to research con-
currently published in “Highly Efﬁcient Generation of Glutama-
tergic/Cholinergic NT2-Derived Postmitotic Human Neurons by
Short-Term treatment with the Nucleoside Analogue Cytosine β-D-
Arabinofuranoside” [1].
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ject areaNeuronal differentiationype of data Text ﬁle, graph, and ﬁgure
ow data was
acquiredEpiﬂuorescence microscope for detection of β-III tubulin, NeuN/Fox-3 and
Hoechst 33342 signals, NIH ImageJ software for morphometrical analysis,
GraphPad Prism 5.0 software for statistical analysisata format Processed images, analyzed data
xperimental
factorsNT2 progenitors were induced to differentiate with either retinoic acid (RA) or
cytosine β-D-Arabinofuranoside (AraC)
xperimental
featuresImages of immunostained neurons derived from NT2 progenitors were acquired
with an epiﬂuorescence microscope and subjected to morphometric analysisata source
locationDepartment of Pharmacology, Faculty of Pharmacy, University of the Basque
Country (UPV/EHU), Spainata accessibility Data is provided within the articleDValue of the data The present data describe a reliable methodology to morphometrically distinguish different neu-
ronal phenotypes in vitro.
 By combining phenotype markers and morphometric analysis, data provide a methodological
approach to differentiate stem cell-derived neuronal and non-neuronal phenotypes.
 These data are useful for researchers interested in stem cell-derived neurons.1. Data
Pluripotent NTERA2/D1 (NT2) human teratocarcinoma cells induced to differentiate into post-
mitotic neurons (NT2N neurons) by either short-term treatment (6 days) with cytosine β-D-
arabinofuranoside (AraC) [1,2] (Fig. 1A–F) or long-term treatment (4 weeks) with retinoic acid (RA)
[1,3,4] (Fig. 1G–J) were morphometrically analyzed. The data obtained were statistically treated and
used for comparison between AraC- and RA-differentiated neurons (AraC/NT2N and RA/NT2N neu-
rons, respectively). Mean values (7SEM) for nuclear area, average neurite length per cell, area of the
soma, number of neurites per cell, ratio of nuclear area to the body area and total neurite length per
cell, resulting from morphometric analysis of AraC/NT2N and RA/NT2N neurons, are shown in Fig. 1K.2. Experimental design, materials and methods
2.1. Immunoﬂuorescence labeling
NT2 progenitors were cultured and induced to differentiate into NT2N postmitotic neurons using
either cytosine β-D-Arabinofuranoside (AraC) or retinoic acid (RA) as previously described in our
laboratory [1], thus obtaining cultures highly enriched in AraC/NT2N or RA/NT2N postmitotic neu-
rons. Because β-III tubulin was expressed in cell bodies and throughout all neurites of differentiated
AraC/NT2N and RA/NT2N cells, delivering at the same time high contrast [1], we chose an antibody
against β-III tubulin as the primary marker for measurements of area of neuronal body and neurite
length in both neuronal phenotypes. Additionally, AraC-treated cultures were co-immunolabeled
Fig. 1. Illustration of image processing for morphometric analysis of NT2N neurons obtained by treatment with 20 mM AraC
(AraC/NT2N, A–F) for 6 days or 10 mM RA (RA/NT2N, G–I) for 4 weeks. Mosaic images of cell cultures processed for immu-
nolabeling with β-III tubulin (green) combined with Hoechst’ staining (blue) were captured under either a 20X (A) or a 40X
objective (G). Binarized images of Hoechst-stained nuclei (B,H) and inverted grayscale images of β-III tubulin immunostaining
(D–I) were used to measure the area of neuronal nuclei and bodies (E,J). In AraC-treated cultures, co-immunostaining for NeuN/
Fox-3 (red) and β-III tubulin (A,C) was used to identify non-neuronal (arrows in A–F; light gray-ﬁlled cells in F) and neuronal
(arrowheads in A–F; dark gray-ﬁlled cells in F) phenotypes, which were subjected to additional morphometric analysis with
nuclear and whole cell areas as variables (see Materials and methods). In contrast, RA/NT2N neurons (arrowheads in G–J) could
be easily distinguished from non-neuronal cells (arrows in G–J) by their size and morphology. Scale bars¼100 mm. K. Bar
graphs showing values obtained from morphometric analyses. All data represent average values obtained from 99 cells in
3 independent experiments. Two-tailed unpaired t-test (Mean7SEM; n¼3; ***, po0.0001; N/S, not signiﬁcant).
I. González-Burguera et al. / Data in Brief 7 (2016) 1349–1354 1351with an antibody against the neuronal marker NeuN/Fox-3, which served to establish a double cri-
terion classify cells as neuronal or non-neuronal (see below).
For immunoﬂuorescence labeling, cells were ﬁxed, for 10 min at 20–25 °C, with 4% paraformaldehyde
in phosphate-buffered saline 0.1 M, pH 7.4 (PBS). After 3 washes (10 min each) at 20–25 °C with washing
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Aldrich, St Louis, MO, USA), cells were incubated at 4 °C for 1 h with permeabilizing blocking buffer
(washing buffer, containing 0.05% saponin, Sigma-Aldrich, and 1% normal serum from the species in
which the secondary antibody was raised). Thereafter, cells were incubated with primary antibodies
diluted with permeabilizing blocking buffer at 4 °C overnight. As primary antibody against β-III tubulin,
we used the afﬁnity-puriﬁed chicken polyclonal antibody to β-III tubulin (1:1,000; Abcam, ab41489),
either alone (for single immunoﬂuorescence) or combined (for double immunoﬂuorescence) with mouse
monoclonal to NeuN/Fox-3 (1:1000; Millipore, MAB377, clone A60). After 3 washes (10 min each) at 20–
25 °C with washing buffer, cells were incubated with the appropriate ﬂuorescent dye-conjugated sec-
ondary antibodies diluted with permeabilizing blocking buffer for 1 h at 20–25 °C. Thus, Dylight 488
Donkey anti-Chicken IgG secondary antibody (1:400; Jackson Immunoresearch Laboratories, Inc.; West
Grove, PA, USA, 703-486-155) was used either alone, for single β-III tubulin immunoﬂuorescence, or
combined with Alexa Fluor 568 Goat anti-Mouse IgG (Invitrogen Molecular Probes, Spain, A-11031), for
double immunoﬂuorescence against β-III tubulin and NeuN/Fox-3. Both secondary antibodies consist of
afﬁnity-puriﬁed IgGs adsorbed against several species to prevent undesired cross-reactions in double
immunolabeling experiments. After the secondary antibody incubation, cells were washed once with
washing buffer for 10 min at 20–25 °C. Cell nuclei were then counterstained with Hoechst 33342 (Sigma-
Aldrich, diluted to 0.1 mg/mL with washing buffer) for 10 min at 20–25 °C. After 2 additional washes
(10 min each) at 20–25 °C with washing buffer, cells were mounted onto glass slides using homemade
Mowiol (Calbiochem, Madrid, Spain) mounting medium, containing anti-fade reagent 1,4-phenylene-
diamine dihydrochloride (Sigma-Aldrich).
2.2. Morphometric analyses
RA/NT2N neurons could be easily distinguished from the remaining non-neuronal cells on the
basis of their much stronger β-III tubulin immunostaining intensity and morphological features. In
contrast, both AraC/NT2N neurons and non-neuronal cells remaining after the 6-day period of
treatment with AraC were strongly immunopositive for β-III tubulin and, consequently, could not be
distinguished from AraC/NT2N neurons on the basis of the expression of this neuronal marker. Thus,
to identify neuronal and non-neuronal cells in cultures treated with AraC for 6 days, absence of or
very weak immunolabeling for the neuronal marker NeuN/Fox-3 was used as the ﬁrst cut-off cri-
terion to classify cells as non-neuronal. Additionally, cells showing weak to moderate immunor-
eactivity for NeuN/Fox-3 but displaying ﬂat polygonal morphologies and no neurites were also
classiﬁed as non-neuronal (Fig. 1A–F, arrows), whereas cells showing NeuN/Fox-3 positive nucleus
and neurite extensions were classiﬁed as AraC/NT2N neurons (Fig. 1A–F, arrowheads). Hence,
morphometric analysis of terminally differentiated AraC/NT2N neurons and non-neuronal cells
remaining after the 6-day period of treatment with AraC was performed on ﬂuorescence micro-
scope images of cells doubly stained for β-III tubulin and NeuN/Fox-3, and counterstained with
Hoechst 33342 (Fig. 1A–F), whereas morphometric analysis of RA/NT2N neurons was performed on
ﬂuorescence microscope images of cells immunostained for β-III tubulin and counterstained with
Hoechst 33342 (Fig. 1G–J).
Cells were imaged by conventional epiﬂuorescence using a Carl Zeiss Axio Observer.Z1 micro-
scope, equipped with a HXP120C metal halide lamp and a XYZ motorized stage (all from Carl Zeiss
MicroImaging, Inc, Gottingen, Germany). Immunolabeled AraC/NT2N and RA/NT2N neurons were
imaged using 20x Plan-Apochromat (NA 0.8; pixel size 0.3220.322 mm2) and 40x EC Plan Neoﬂuar
(NA 0.75; pixel size 0.1610.161 mm2) objectives (both from Carl Zeiss MicroImaging, Inc), respec-
tively. Bandpass ﬁlters used (all from Carl Zeiss MicroImaging, Inc) were 38 HE eGFP (Ex 470/40, Em
525/50) for Dylight 488, 43 HE Cy3 shift free (Ex 550/25, Em 605/70) for Alexa Fluor 568 and 49 DAPI
(Ex G 365/Em 445/50) for Hoechst's staining. Monochrome images of each color channel were cap-
tured with a resolution of 13881040 pixels and 16-bit depth using a high-resolution monochro-
matic camera AxioCam MRm (Carl Zeiss MicroImaging, Inc) and digitized using Zeiss Axio Vision
4.8 software (Carl Zeiss MicroImaging, Inc). The captured 16-bit images were then converted to TIFF
ﬁles using the ImageJ software (NIH, Bethesda, MA, USA). Multiple images from cultures were taken
using the Carl Zeiss Mosaic module with focus adjustment. Subsequent stitching and aligning
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were performed on 3 mosaic images obtained from 3 independent experiments. A total of 33 cells of
each phenotype (cells classiﬁed as non-neuronal in AraC-treated cultures, AraC/NT2N neurons and
RA/NT2N neurons) were analyzed per mosaic, starting from the center of the image. Fig. 1A–F and G–J
correspond to representative portions of a mosaic images used for morphometric analysis and depict
the different steps of image processing to obtain values of the parameters analyzed. To measure the
area of nuclei, binary images were obtained by thresholding the Hoechst channel (Fig. 1B and H) to
include only nuclei using ImageJ software (NIH). Inverted grayscale images from the β-III tubulin
channel (Fig. 1D and I) allowed visualization of cell bodies of AraC/NT2 and RA/NT2 neurons (Fig. 1E
and J), as well as the whole cell area of AraC-treated cells, including lamellar extensions of AraC/NT2N
neurons (Fig. 1F). The Hoechst channel and inverted grayscale images corresponding to the β-III
tubulin channel were loaded as separate image stacks in ImageJ software. Area of nucleus, area of cell
body and length of neurites was determined for each AraC/NT2N and RA/NT2N neuron. The area of
nuclei was selected (Fig. 1E and J) on the corresponding stack with the wand (tracing) tool of ImageJ
and then measured. Unhealthy or fragmented nuclei and false-positive particles were excluded from
the analysis. Cell somata were manually outlined and their area measured (Fig. 1E and J). When the
boundaries were not clearly deﬁned due to the presence of ﬂat lamellar extensions in AraC/NT2N
neurons, β-III tubulin staining accumulation was used to deﬁne the limits of neuronal bodies (Fig. 1E).
Neurites were traced using the segmented line tool and their length measured (Fig. 1E and J).
Additionally, after manually tracing cell boundaries using the polygon selection tool, the total area
(including nuclei) of neuronal and non-neuronal cells generated by treatment with AraC for 6 days
was measured using the grayscale-converted images corresponding to the β-III tubulin channel
(schematically illustrated in Fig. 1F). The data from this analysis are shown in González-Burguera et al.
(2016, Fig. 3) [1] and served to assess whether phenotypes classiﬁed as neuronal and non-neuronal
after AraC-induced differentiation were morphometrically distinguishable.
2.3. Statistical analysis
All data represent average values obtained from 99 cells in 3 independent experiments (33 cells/
experiment). Results were statistically analyzed in GraphPad Prism (version 5.0, GraphPad Software
Inc., San Diego, CA) and presented as mean7SEM. Statistically signiﬁcant differences between two
groups were assessed by two-tailed unpaired t-test. po0.05 was considered signiﬁcant.Acknowledgments
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